De Cock, V. C., Dodet, P., Leu-Semenescu, S., Aerts, C., Castelnovo, G., Abril, B., Drapier, S., Olivet, H., Corbillé, A., Leclair-Visonneau, L., Sallansonnet-Froment, M., Lebouteux, M., Anheim, M., Ruppert, E., Vitello, N., Eusebio, A., Lambert, I., Marques, A., Fantini, M. L., Devos, D., Monaca, C., Benard-Serre, N., Lacombe, S., Vidailhet, M., Arnulf, I., Doulazmi, M., & Roze, E. (2022). safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study. Lancet neurology, 21(5), 428–437. http://access.bl.uk/ark:/81055/vdc_100153446876.0x000013